30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Yat Sun Or

Insider profile

Currently holds a position at Enanta Pharmaceuticals Inc

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 70% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Senior Vice President - Research & Development, Chief Scientific Officer Enanta Pharmaceuticals Inc Nov. 1, 1999 -

Yat Sun Or's trades of Enanta Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-05 2025-12-05 S Sale
89,458 -8.6%
405.77
US$3,940,345
89,458 -8.6% 405.77 US$3,940,345
2024-12-10 2024-12-06 S Sale
78,460 +38.3%
281.23
US$1,766,797
78,460 +38.3% 281.23 US$1,766,797
2023-12-06 2023-12-05 S Sale
83,530 -21.3%
460.13
US$46,594
83,530 -21.3% 460.13 US$46,594
2023-03-17 2023-03-15 PlS Planned sale
13,656 -3.5%
44.46
US$607,146
13,656 -3.5% 44.46 US$607,146
2023-03-17 2023-03-15 PlS Planned sale
269 -0.1%
43.92
US$11,814
269 -0.1% 43.92 US$11,814
2019-03-04 2019-03-01 PlS Planned sale
4,090 -1.3%
103.84
US$424,693
4,090 -1.3% 103.84 US$424,693
2019-03-04 2019-03-01 PlS Planned sale
5,910 -1.9%
103.32
US$610,628
5,910 -1.9% 103.32 US$610,628
2019-02-13 2019-02-12 PlS Planned sale
6,297 -2.0%
90.07
US$567,173
6,297 -2.0% 90.07 US$567,173
2019-02-13 2019-02-11 PlS Planned sale
171 -0.1%
91.24
US$15,602
171 -0.1% 91.24 US$15,602
2019-02-13 2019-02-11 PlS Planned sale
2,707 -0.9%
90.11
US$243,936
2,707 -0.9% 90.11 US$243,936
2019-02-13 2019-02-11 PlS Planned sale
18,971 -5.7%
89.50
US$1,697,878
18,971 -5.7% 89.50 US$1,697,878
2019-02-13 2019-02-11 PlS Planned sale
5,835 -1.7%
88.66
US$517,321
5,835 -1.7% 88.66 US$517,321